These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17001219)

  • 1. Prevalence and characteristics of impaired glucose metabolism in patients referred to comprehensive cardiac rehabilitation: the DANSUK study.
    Boas Soja AM; Zwisler AD; Melchior T; Hommel E; Torp-Pedersen C; Madsen M
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):784-90. PubMed ID: 17001219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intensified comprehensive cardiac rehabilitation to improve risk factor control in patients with type 2 diabetes mellitus or impaired glucose tolerance--the randomized DANish StUdy of impaired glucose metabolism in the settings of cardiac rehabilitation (DANSUK) study.
    Soja AM; Zwisler AD; Frederiksen M; Melchior T; Hommel E; Torp-Pedersen C; Madsen M
    Am Heart J; 2007 Apr; 153(4):621-8. PubMed ID: 17383302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of diabetes mellitus and other abnormalities of glucose tolerance in young adults aged 20-40 years in North India (Kashmir Valley).
    Zargar AH; Wani AA; Laway BA; Masoodi SR; Wani AI; Bashir MI; Dar FA
    Diabetes Res Clin Pract; 2008 Nov; 82(2):276-81. PubMed ID: 18814927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
    Adam JM; Tarigan NP
    Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
    Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
    Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.
    Cambuli VM; Incani M; Pilia S; Congiu T; Cavallo MG; Cossu E; Sentinelli F; Mariotti S; Loche S; Baroni MG
    Diabetes Metab Res Rev; 2009 Sep; 25(6):528-34. PubMed ID: 19496065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon.
    Sharif A; Moore RH; Baboolal K
    Transplantation; 2006 Dec; 82(12):1667-72. PubMed ID: 17198257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of the glucose metabolism disturbances in screening of adult inhabitants of Krakow].
    Szurkowska M; Szafraniec K; Gilis-Januszewska A; Pach D; Krzentowska A; Szybiński Z; Huszno B
    Przegl Lek; 2006; 63(9):728-32. PubMed ID: 17479858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
    Elbert A; Schreier L; Galli C; Beresan H; Lopez G; Traversa M; Berg G
    J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
    Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
    J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining genetic markers and clinical risk factors improves the risk assessment of impaired glucose metabolism.
    Ruchat SM; Vohl MC; Weisnagel SJ; Rankinen T; Bouchard C; Pérusse L
    Ann Med; 2010 Apr; 42(3):196-206. PubMed ID: 20384434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysglycaemia in vascular surgery patients.
    Astor M; Søfteland E; Daryapeyma A; Jonung T
    Eur J Vasc Endovasc Surg; 2010 Apr; 39(4):447-51. PubMed ID: 20149695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.
    Guerrero-Romero F; Rodríguez-Morán M
    Eur J Clin Invest; 2006 Nov; 36(11):796-802. PubMed ID: 17032347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of ADA and WHO diagnostic criteria for diabetes diagnosis and other categories of glucose intolerance ].
    Herdzik E; Safranow K; Ciechanowski K; Byra E; Gołdyn U
    Pol Merkur Lekarski; 2002 Oct; 13(76):316-20. PubMed ID: 12557440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
    Guerrero-Romero F; Violante R; Rodríguez-Morán M
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reappraisal of the characteristics of glucose abnormalities in patients with chronic hepatitis C infection.
    Huang JF; Yu ML; Dai CY; Hsieh MY; Hwang SJ; Hsiao PJ; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Shin SJ; Chang WY; Chuang WL
    Am J Gastroenterol; 2008 Aug; 103(8):1933-40. PubMed ID: 18637090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screen detected subjects with type 2 diabetes and impaired glucose tolerance have more adverse cardiovascular risk than subjects with impaired fasting glucose especially when they are obese: the ADDITION Netherlands study.
    Janssen PG; Gorter KJ; Stolk RP; Rutten GE
    Prim Care Diabetes; 2007 Jun; 1(2):69-74. PubMed ID: 18632022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should oral glucose tolerance test be a routine examination after a myocardial infarction?
    Henareh L; Berglund M; Agewall S
    Int J Cardiol; 2004 Oct; 97(1):21-4. PubMed ID: 15336801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.